Hrt Financial LP Applied Genetic Technologies Corp Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.62 - $1.1 $43,112 - $76,489
69,536 New
69,536 $53,000
Q4 2021

Feb 14, 2022
SELL
$1.87 - $2.91 $107,294 - $166,967
-57,377 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$3.01 - $4.12 $203,840 - $279,010
-67,721 Reduced 54.13%
57,377 $172,000
Q2 2021

Aug 16, 2021
BUY
$3.62 - $5.23 $452,854 - $654,262
125,098 New
125,098 $489,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email